H1B Report
Side-by-side comparison

Foundation Medicine, Inc. vs INFOSYS LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Foundation Medicine, Inc.
MARank #FEIN 27-1316416
Entity B
INFOSYS LIMITED
TXRank #1FEIN 58-1760235

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricFoundation Medicine, Inc.INFOSYS LIMITED
Total filings314205,263
Certified %93.31%99.55%
Denied %0.64%0.21%
Withdrawn %1.91%0.20%
Cert-withdrawn %4.14%0.05%
Rank#1
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateMATX

Outcomes — Foundation Medicine, Inc.

DOL case-status mix.

Outcome breakdown: Certified 93.3%, Cert-withdrawn 4.1%, Withdrawn 1.9%, Denied 0.6%
Outcome breakdown
OutcomeShare
Certified93.3%
Cert-withdrawn4.1%
Withdrawn1.9%
Denied0.6%
Certified93.3%
Cert-withdrawn4.1%
Withdrawn1.9%
Denied0.6%

Outcomes — INFOSYS LIMITED

DOL case-status mix.

Outcome breakdown: Certified 99.5%, Cert-withdrawn 0.0%, Withdrawn 0.2%, Denied 0.2%
Outcome breakdown
OutcomeShare
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Foundation Medicine, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201010
FY201115
FY201215
FY201312
FY201414
FY201522
FY201637
FY201731
FY201827
FY201933
FY20200
FY20214
FY20222
FY202310
FY202442
FY202526
FY202614
INFOSYS LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,164
FY20111,681
FY201214,701
FY201332,232
FY201423,749
FY201533,214
FY201625,335
FY201720,571
FY201811,569
FY201921,420
FY202016
FY202129
FY202222
FY20232,269
FY20245,943
FY20255,790
FY20264,558

Top 5 occupations — Foundation Medicine, Inc.

Top 5 occupations — INFOSYS LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.